Search Within

Ekaterina Doubrovina

Formats
  1. Meeting Abstract (66)
  2. Journal Article (32)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. GSK Faculty (97)
  2. Sloan Kettering Institute Faculty (97)
  3. Department of Medicine (95)
  4. Pediatrics, Department of (95)
  5. Stem Cell Transplantation and Cellular Therapy Service (95)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (94)

More Groups

People
  1. Richard O'Reilly (94)
  2. Susan Prockop (46)
  3. Aisha Hasan (32)
  4. Guenther Koehne (28)
  5. Mikhail Doubrovin (23)
  6. Nancy Kernan (18)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2021 (3)
  4. 2020 (7)
  5. 2019 (4)
  6. 2018 (3)

More Years

Publications
  1. Blood (37)
  2. Biology of Blood and Marrow Transplantation (15)
  3. Bone Marrow Transplantation (5)
  4. Cancer Research (5)
  5. Cytotherapy (4)
  6. Journal of Clinical Oncology (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Elsevier Inc. (18)
  3. American Association for Cancer Research (7)
  4. Nature Publishing Group (7)
  5. Elsevier Science Ltd. (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV plus post-transplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Aftab, B. T.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Prockop, S.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Epigenetic reprogramming sensitizes immunologically silent EBV(+) lymphomas to virus-directed immunotherapy
    Journal Article

    Dalton, T.; Doubrovina, E.; Pankov, D.; Reynolds, R.; Scholze, H.; Selvakumar, A.; Vizconde, T.; Savalia, B.; Dyomin, V.; Weigel, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Efficacy of donor and 'third party' (Tabelecleucel) EBV-specific T cells for treatment of central nervous system (CNS) EBV-PTLD
    Meeting Abstract

    Prockop, S. E.; Suser, S.; Doubrovina, E. S.; Castro-Malaspina, H.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Therapeutic advantages provided by banked virus-specific T-cells of defined HLA-restriction
    Review

    O’Reilly, R. J.; Prockop, S.; Hasan, A.; Doubrovina, E.
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Durable responses to 3rd party viral specific T cells mediated by different patterns of engraftment
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; Suser, S.; Rodriguez-Sanchez, I.; Price, K.; Slocum, A.; O'Reilly, R. J.
    Cytotherapy (2019)

    Fulltext@MSK | Save
  • In T-cell lines dually sensitized with antigens from EBV and CMV or from EBV and WT1 the T-cells specific for CMV or WT1 are often restricted by HLA alleles that differ from those restricting T-cells specific for EBV
    Meeting Abstract

    Doubrovina, E.; Hasan, A.; Prockop, S.; O'Reilly, R. J.
    Cytotherapy (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of tabelecleucel in patients with EpsteinBarr Virus-associated leiomyosarcomas (EBV(+)LMS)
    Meeting Abstract

    Kurlander, L. S.; Srinivasan, A.; Ghobadi, A.; Suser, S.; Doubrovina, E.; Boulad, F.; Mascarenhas, L.; Laquaglia, M.; Price, A.; Behr, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Adoptive therapy with EBV-specific T cells for treatment of CNS EBV post-transplant lymphoproliferative disease arising after hematopoietic stem cell transplant or solid organ transplant
    Meeting Abstract

    Prockop, S.; Suser, S.; Doubrovina, E.; Castro-Malaspina, H. R.; Papadopoulos, E. B.; Sauter, C. S.; Young, J. W.; Szenes, V.; Slocum, A.; Baroudy, K.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save